nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—ADRB1—stomach cancer	0.32	0.528	CbGaD
Dopamine—HTR1A—stomach cancer	0.287	0.472	CbGaD
Dopamine—SLC22A3—Irinotecan—stomach cancer	0.0745	0.598	CbGbCtD
Dopamine—CYP2C9—Capecitabine—stomach cancer	0.0196	0.157	CbGbCtD
Dopamine—CYP1A2—Fluorouracil—stomach cancer	0.0129	0.103	CbGbCtD
Dopamine—CYP2C9—Fluorouracil—stomach cancer	0.0116	0.0932	CbGbCtD
Dopamine—HTR7—myenteric nerve plexus—stomach cancer	0.00804	0.111	CbGeAlD
Dopamine—Piloerection—Irinotecan—stomach cancer	0.00696	0.132	CcSEcCtD
Dopamine—CYP2D6—Doxorubicin—stomach cancer	0.00605	0.0485	CbGbCtD
Dopamine—HTR7—vagus nerve—stomach cancer	0.00536	0.0739	CbGeAlD
Dopamine—HTR7—vein—stomach cancer	0.00518	0.0714	CbGeAlD
Dopamine—Necrosis—Mitomycin—stomach cancer	0.00354	0.0671	CcSEcCtD
Dopamine—Extravasation—Mitomycin—stomach cancer	0.00319	0.0604	CcSEcCtD
Dopamine—DBH—hematopoietic system—stomach cancer	0.00238	0.0329	CbGeAlD
Dopamine—Angina pectoris—Floxuridine—stomach cancer	0.00216	0.041	CcSEcCtD
Dopamine—DRD5—hematopoietic system—stomach cancer	0.00183	0.0253	CbGeAlD
Dopamine—DBH—digestive system—stomach cancer	0.00166	0.0229	CbGeAlD
Dopamine—HTR7—blood vessel—stomach cancer	0.00164	0.0227	CbGeAlD
Dopamine—DBH—bone marrow—stomach cancer	0.00153	0.0211	CbGeAlD
Dopamine—Necrosis—Fluorouracil—stomach cancer	0.00147	0.0279	CcSEcCtD
Dopamine—Extravasation—Irinotecan—stomach cancer	0.00138	0.0262	CcSEcCtD
Dopamine—DBH—endocrine gland—stomach cancer	0.00137	0.0189	CbGeAlD
Dopamine—Extravasation—Fluorouracil—stomach cancer	0.00132	0.0251	CcSEcCtD
Dopamine—DRD5—lymphoid tissue—stomach cancer	0.00129	0.0178	CbGeAlD
Dopamine—COMT—hematopoietic system—stomach cancer	0.00126	0.0174	CbGeAlD
Dopamine—DBH—liver—stomach cancer	0.00124	0.017	CbGeAlD
Dopamine—Azotaemia—Methotrexate—stomach cancer	0.00113	0.0214	CcSEcCtD
Dopamine—SLC6A3—hematopoietic system—stomach cancer	0.00113	0.0155	CbGeAlD
Dopamine—COMT—smooth muscle tissue—stomach cancer	0.00111	0.0153	CbGeAlD
Dopamine—SLC22A2—digestive system—stomach cancer	0.00109	0.0151	CbGeAlD
Dopamine—Necrosis—Docetaxel—stomach cancer	0.00106	0.0201	CcSEcCtD
Dopamine—SLC22A3—hematopoietic system—stomach cancer	0.00106	0.0146	CbGeAlD
Dopamine—Masoprocol—ALOX5—stomach cancer	0.00106	0.124	CrCbGaD
Dopamine—DRD5—endocrine gland—stomach cancer	0.00105	0.0145	CbGeAlD
Dopamine—Hypertension—Mitomycin—stomach cancer	0.00105	0.0199	CcSEcCtD
Dopamine—SLC6A4—hematopoietic system—stomach cancer	0.00103	0.0142	CbGeAlD
Dopamine—COMT—pancreas—stomach cancer	0.00103	0.0142	CbGeAlD
Dopamine—MAOB—hematopoietic system—stomach cancer	0.000981	0.0135	CbGeAlD
Dopamine—Extrasystoles—Capecitabine—stomach cancer	0.00096	0.0182	CcSEcCtD
Dopamine—Extravasation—Docetaxel—stomach cancer	0.000956	0.0181	CcSEcCtD
Dopamine—Isoprenaline—MAPK1—stomach cancer	0.000952	0.111	CrCbGaD
Dopamine—DBH—lymph node—stomach cancer	0.000947	0.0131	CbGeAlD
Dopamine—SLC22A3—smooth muscle tissue—stomach cancer	0.000933	0.0129	CbGeAlD
Dopamine—HTR1A—hematopoietic system—stomach cancer	0.000916	0.0126	CbGeAlD
Dopamine—Dyspnoea—Mitomycin—stomach cancer	0.000884	0.0168	CcSEcCtD
Dopamine—COMT—digestive system—stomach cancer	0.000876	0.0121	CbGeAlD
Dopamine—HTR7—hematopoietic system—stomach cancer	0.000875	0.0121	CbGeAlD
Dopamine—CYP2C19—hematopoietic system—stomach cancer	0.000855	0.0118	CbGeAlD
Dopamine—Cyanosis—Methotrexate—stomach cancer	0.00085	0.0161	CcSEcCtD
Dopamine—MAOA—hematopoietic system—stomach cancer	0.000837	0.0115	CbGeAlD
Dopamine—COMT—bone marrow—stomach cancer	0.000808	0.0111	CbGeAlD
Dopamine—Vomiting—Floxuridine—stomach cancer	0.000803	0.0152	CcSEcCtD
Dopamine—HTR7—epithelium—stomach cancer	0.0008	0.011	CbGeAlD
Dopamine—Headache—Floxuridine—stomach cancer	0.000792	0.015	CcSEcCtD
Dopamine—Mesalazine—ALOX5—stomach cancer	0.000773	0.0903	CrCbGaD
Dopamine—HTR7—smooth muscle tissue—stomach cancer	0.000771	0.0106	CbGeAlD
Dopamine—Necrosis—Methotrexate—stomach cancer	0.000766	0.0145	CcSEcCtD
Dopamine—Ventricular arrhythmia—Epirubicin—stomach cancer	0.00076	0.0144	CcSEcCtD
Dopamine—Nausea—Floxuridine—stomach cancer	0.00075	0.0142	CcSEcCtD
Dopamine—Angina pectoris—Irinotecan—stomach cancer	0.000738	0.014	CcSEcCtD
Dopamine—COMT—endocrine gland—stomach cancer	0.000724	0.00999	CbGeAlD
Dopamine—Dobutamine—CA2—stomach cancer	0.000719	0.084	CrCbGaD
Dopamine—SLC6A4—digestive system—stomach cancer	0.000717	0.00989	CbGeAlD
Dopamine—Necrosis—Epirubicin—stomach cancer	0.000717	0.0136	CcSEcCtD
Dopamine—Angina pectoris—Fluorouracil—stomach cancer	0.000706	0.0134	CcSEcCtD
Dopamine—Ventricular arrhythmia—Doxorubicin—stomach cancer	0.000703	0.0133	CcSEcCtD
Dopamine—CYP1A2—hematopoietic system—stomach cancer	0.000698	0.00962	CbGeAlD
Dopamine—Extravasation—Methotrexate—stomach cancer	0.000689	0.0131	CcSEcCtD
Dopamine—Isoetarine—ADRB1—stomach cancer	0.000684	0.0799	CrCbGaD
Dopamine—MAOB—digestive system—stomach cancer	0.000682	0.0094	CbGeAlD
Dopamine—MAOA—pancreas—stomach cancer	0.000681	0.00939	CbGeAlD
Dopamine—Necrosis—Doxorubicin—stomach cancer	0.000663	0.0126	CcSEcCtD
Dopamine—CYP2C9—hematopoietic system—stomach cancer	0.000663	0.00914	CbGeAlD
Dopamine—COMT—liver—stomach cancer	0.000653	0.009	CbGeAlD
Dopamine—Extravasation—Epirubicin—stomach cancer	0.000645	0.0122	CcSEcCtD
Dopamine—Atrial fibrillation—Docetaxel—stomach cancer	0.000639	0.0121	CcSEcCtD
Dopamine—SLC22A1—endocrine gland—stomach cancer	0.000637	0.00878	CbGeAlD
Dopamine—Vomiting—Mitomycin—stomach cancer	0.00063	0.0119	CcSEcCtD
Dopamine—Headache—Mitomycin—stomach cancer	0.000621	0.0118	CcSEcCtD
Dopamine—Atrial fibrillation—Capecitabine—stomach cancer	0.000619	0.0117	CcSEcCtD
Dopamine—Bradycardia—Irinotecan—stomach cancer	0.000617	0.0117	CcSEcCtD
Dopamine—ADRB1—endocrine gland—stomach cancer	0.000613	0.00846	CbGeAlD
Dopamine—SLC22A3—endocrine gland—stomach cancer	0.000609	0.0084	CbGeAlD
Dopamine—HTR7—digestive system—stomach cancer	0.000609	0.00839	CbGeAlD
Dopamine—Extravasation—Doxorubicin—stomach cancer	0.000597	0.0113	CcSEcCtD
Dopamine—CYP2C19—digestive system—stomach cancer	0.000594	0.00819	CbGeAlD
Dopamine—SLC6A4—endocrine gland—stomach cancer	0.000593	0.00817	CbGeAlD
Dopamine—Nausea—Mitomycin—stomach cancer	0.000589	0.0112	CcSEcCtD
Dopamine—MAOA—digestive system—stomach cancer	0.000582	0.00802	CbGeAlD
Dopamine—Isoetarine—ADRB2—stomach cancer	0.000575	0.0672	CrCbGaD
Dopamine—SLC22A1—liver—stomach cancer	0.000574	0.00792	CbGeAlD
Dopamine—MAOB—endocrine gland—stomach cancer	0.000563	0.00777	CbGeAlD
Dopamine—SLC22A3—liver—stomach cancer	0.000549	0.00757	CbGeAlD
Dopamine—SLC22A5—digestive system—stomach cancer	0.000536	0.00739	CbGeAlD
Dopamine—HTR1A—endocrine gland—stomach cancer	0.000526	0.00726	CbGeAlD
Dopamine—SLC6A2—endocrine gland—stomach cancer	0.000522	0.00719	CbGeAlD
Dopamine—Angina pectoris—Docetaxel—stomach cancer	0.00051	0.00966	CcSEcCtD
Dopamine—MAOB—liver—stomach cancer	0.000508	0.007	CbGeAlD
Dopamine—HTR7—endocrine gland—stomach cancer	0.000503	0.00693	CbGeAlD
Dopamine—COMT—lymph node—stomach cancer	0.000501	0.0069	CbGeAlD
Dopamine—Dobutamine—ADRB1—stomach cancer	0.0005	0.0585	CrCbGaD
Dopamine—CYP2D6—hematopoietic system—stomach cancer	0.000497	0.00686	CbGeAlD
Dopamine—Angina pectoris—Capecitabine—stomach cancer	0.000494	0.00936	CcSEcCtD
Dopamine—CYP2C19—endocrine gland—stomach cancer	0.000491	0.00677	CbGeAlD
Dopamine—CYP1A2—digestive system—stomach cancer	0.000485	0.00669	CbGeAlD
Dopamine—MAOA—endocrine gland—stomach cancer	0.000481	0.00663	CbGeAlD
Dopamine—DRD2—endocrine gland—stomach cancer	0.000475	0.00656	CbGeAlD
Dopamine—CYP2C9—digestive system—stomach cancer	0.000461	0.00635	CbGeAlD
Dopamine—Hypertension—Irinotecan—stomach cancer	0.000455	0.00863	CcSEcCtD
Dopamine—HTR7—liver—stomach cancer	0.000453	0.00625	CbGeAlD
Dopamine—CYP2C19—liver—stomach cancer	0.000443	0.00611	CbGeAlD
Dopamine—Mesalazine—PPARG—stomach cancer	0.000442	0.0517	CrCbGaD
Dopamine—MAOA—liver—stomach cancer	0.000433	0.00598	CbGeAlD
Dopamine—SLC22A3—lymph node—stomach cancer	0.000421	0.0058	CbGeAlD
Dopamine—Dobutamine—ADRB2—stomach cancer	0.000421	0.0492	CrCbGaD
Dopamine—Bradycardia—Capecitabine—stomach cancer	0.000413	0.00783	CcSEcCtD
Dopamine—Tachycardia—Fluorouracil—stomach cancer	0.000402	0.00763	CcSEcCtD
Dopamine—CYP1A2—endocrine gland—stomach cancer	0.000401	0.00553	CbGeAlD
Dopamine—SLC22A5—liver—stomach cancer	0.000399	0.0055	CbGeAlD
Dopamine—MAOB—lymph node—stomach cancer	0.000389	0.00537	CbGeAlD
Dopamine—Dyspnoea—Irinotecan—stomach cancer	0.000384	0.00727	CcSEcCtD
Dopamine—CYP2C9—endocrine gland—stomach cancer	0.000381	0.00525	CbGeAlD
Dopamine—Dyspnoea—Fluorouracil—stomach cancer	0.000368	0.00697	CcSEcCtD
Dopamine—CYP1A2—liver—stomach cancer	0.000362	0.00499	CbGeAlD
Dopamine—SLC6A2—lymph node—stomach cancer	0.000361	0.00497	CbGeAlD
Dopamine—CYP2D6—digestive system—stomach cancer	0.000346	0.00477	CbGeAlD
Dopamine—Angina pectoris—Epirubicin—stomach cancer	0.000344	0.00652	CcSEcCtD
Dopamine—CYP2C9—liver—stomach cancer	0.000343	0.00473	CbGeAlD
Dopamine—MAOA—lymph node—stomach cancer	0.000332	0.00458	CbGeAlD
Dopamine—Palpitations—Docetaxel—stomach cancer	0.000322	0.00611	CcSEcCtD
Dopamine—Angina pectoris—Doxorubicin—stomach cancer	0.000318	0.00603	CcSEcCtD
Dopamine—Hypertension—Docetaxel—stomach cancer	0.000315	0.00597	CcSEcCtD
Dopamine—Droxidopa—ADRB1—stomach cancer	0.000312	0.0365	CrCbGaD
Dopamine—Palpitations—Capecitabine—stomach cancer	0.000312	0.00591	CcSEcCtD
Dopamine—SLC22A5—lymph node—stomach cancer	0.000306	0.00422	CbGeAlD
Dopamine—Hypertension—Capecitabine—stomach cancer	0.000305	0.00578	CcSEcCtD
Dopamine—Anxiety—Capecitabine—stomach cancer	0.0003	0.00568	CcSEcCtD
Dopamine—Tachycardia—Docetaxel—stomach cancer	0.00029	0.00551	CcSEcCtD
Dopamine—Bradycardia—Epirubicin—stomach cancer	0.000288	0.00545	CcSEcCtD
Dopamine—CYP2D6—endocrine gland—stomach cancer	0.000286	0.00394	CbGeAlD
Dopamine—Isoprenaline—ADRB1—stomach cancer	0.000284	0.0332	CrCbGaD
Dopamine—Tachycardia—Capecitabine—stomach cancer	0.000281	0.00533	CcSEcCtD
Dopamine—Vomiting—Irinotecan—stomach cancer	0.000274	0.00519	CcSEcCtD
Dopamine—Headache—Irinotecan—stomach cancer	0.00027	0.00511	CcSEcCtD
Dopamine—Bradycardia—Doxorubicin—stomach cancer	0.000266	0.00504	CcSEcCtD
Dopamine—Dyspnoea—Docetaxel—stomach cancer	0.000265	0.00503	CcSEcCtD
Dopamine—Norepinephrine—ADRB1—stomach cancer	0.000263	0.0307	CrCbGaD
Dopamine—Droxidopa—ADRB2—stomach cancer	0.000263	0.0307	CrCbGaD
Dopamine—Vomiting—Fluorouracil—stomach cancer	0.000262	0.00497	CcSEcCtD
Dopamine—Headache—Fluorouracil—stomach cancer	0.000258	0.0049	CcSEcCtD
Dopamine—CYP2D6—liver—stomach cancer	0.000258	0.00355	CbGeAlD
Dopamine—Dyspnoea—Capecitabine—stomach cancer	0.000257	0.00487	CcSEcCtD
Dopamine—Nausea—Irinotecan—stomach cancer	0.000256	0.00485	CcSEcCtD
Dopamine—Nausea—Fluorouracil—stomach cancer	0.000245	0.00464	CcSEcCtD
Dopamine—Isoprenaline—ADRB2—stomach cancer	0.000239	0.0279	CrCbGaD
Dopamine—Epinephrine—ADRB1—stomach cancer	0.000238	0.0279	CrCbGaD
Dopamine—Epinephrine—TNF—stomach cancer	0.000226	0.0264	CrCbGaD
Dopamine—Norepinephrine—ADRB2—stomach cancer	0.000221	0.0258	CrCbGaD
Dopamine—Palpitations—Epirubicin—stomach cancer	0.000217	0.00412	CcSEcCtD
Dopamine—Hypertension—Epirubicin—stomach cancer	0.000212	0.00402	CcSEcCtD
Dopamine—Anxiety—Epirubicin—stomach cancer	0.000209	0.00396	CcSEcCtD
Dopamine—Palpitations—Doxorubicin—stomach cancer	0.000201	0.00381	CcSEcCtD
Dopamine—Epinephrine—ADRB2—stomach cancer	0.000201	0.0234	CrCbGaD
Dopamine—Hypertension—Doxorubicin—stomach cancer	0.000197	0.00372	CcSEcCtD
Dopamine—Tachycardia—Epirubicin—stomach cancer	0.000196	0.00371	CcSEcCtD
Dopamine—Anxiety—Doxorubicin—stomach cancer	0.000193	0.00366	CcSEcCtD
Dopamine—Dyspnoea—Methotrexate—stomach cancer	0.000191	0.00362	CcSEcCtD
Dopamine—Vomiting—Docetaxel—stomach cancer	0.000189	0.00359	CcSEcCtD
Dopamine—Mesalazine—PTGS2—stomach cancer	0.000187	0.0218	CrCbGaD
Dopamine—Headache—Docetaxel—stomach cancer	0.000186	0.00353	CcSEcCtD
Dopamine—Vomiting—Capecitabine—stomach cancer	0.000183	0.00347	CcSEcCtD
Dopamine—Tachycardia—Doxorubicin—stomach cancer	0.000181	0.00344	CcSEcCtD
Dopamine—Headache—Capecitabine—stomach cancer	0.000181	0.00342	CcSEcCtD
Dopamine—Dyspnoea—Epirubicin—stomach cancer	0.000179	0.00339	CcSEcCtD
Dopamine—Nausea—Docetaxel—stomach cancer	0.000177	0.00335	CcSEcCtD
Dopamine—Nausea—Capecitabine—stomach cancer	0.000171	0.00324	CcSEcCtD
Dopamine—Dyspnoea—Doxorubicin—stomach cancer	0.000166	0.00314	CcSEcCtD
Dopamine—Vomiting—Methotrexate—stomach cancer	0.000136	0.00258	CcSEcCtD
Dopamine—Headache—Methotrexate—stomach cancer	0.000134	0.00255	CcSEcCtD
Dopamine—Vomiting—Epirubicin—stomach cancer	0.000128	0.00242	CcSEcCtD
Dopamine—Nausea—Methotrexate—stomach cancer	0.000127	0.00241	CcSEcCtD
Dopamine—Headache—Epirubicin—stomach cancer	0.000126	0.00238	CcSEcCtD
Dopamine—Nausea—Epirubicin—stomach cancer	0.000119	0.00226	CcSEcCtD
Dopamine—Vomiting—Doxorubicin—stomach cancer	0.000118	0.00224	CcSEcCtD
Dopamine—Headache—Doxorubicin—stomach cancer	0.000116	0.00221	CcSEcCtD
Dopamine—Nausea—Doxorubicin—stomach cancer	0.00011	0.00209	CcSEcCtD
Dopamine—SLC22A1—Metabolism—ALB—stomach cancer	5.45e-06	4.06e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APOA1—stomach cancer	5.44e-06	4.05e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	5.42e-06	4.04e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	5.39e-06	4.02e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—stomach cancer	5.39e-06	4.01e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOS3—stomach cancer	5.39e-06	4.01e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CXCL8—stomach cancer	5.38e-06	4.01e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—HRAS—stomach cancer	5.35e-06	3.98e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—stomach cancer	5.35e-06	3.98e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—MAPK1—stomach cancer	5.33e-06	3.97e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—stomach cancer	5.33e-06	3.97e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CDKN1B—stomach cancer	5.26e-06	3.91e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6R—stomach cancer	5.26e-06	3.91e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCND1—stomach cancer	5.24e-06	3.9e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—JUN—stomach cancer	5.23e-06	3.89e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—NOS3—stomach cancer	5.21e-06	3.88e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—PIK3CA—stomach cancer	5.21e-06	3.88e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PRKCB—stomach cancer	5.19e-06	3.87e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	5.18e-06	3.86e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6ST—stomach cancer	5.17e-06	3.85e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CD44—stomach cancer	5.16e-06	3.84e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	5.16e-06	3.84e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—stomach cancer	5.16e-06	3.84e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	5.15e-06	3.84e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	5.15e-06	3.83e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TYMS—stomach cancer	5.14e-06	3.82e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—PIK3CA—stomach cancer	5.14e-06	3.82e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	5.14e-06	3.82e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—stomach cancer	5.12e-06	3.81e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—stomach cancer	5.11e-06	3.81e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ERBB2—stomach cancer	5.11e-06	3.81e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—KRAS—stomach cancer	5.09e-06	3.79e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MMP9—stomach cancer	5.09e-06	3.79e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTP1—stomach cancer	5.08e-06	3.78e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSTM1—stomach cancer	5.08e-06	3.78e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CDKN1A—stomach cancer	5.07e-06	3.77e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ERBB2—stomach cancer	5.04e-06	3.75e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KRAS—stomach cancer	5.04e-06	3.75e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTP1—stomach cancer	5.04e-06	3.75e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCND1—stomach cancer	5.02e-06	3.73e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—PIK3CA—stomach cancer	5.02e-06	3.73e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—HMOX1—stomach cancer	5.01e-06	3.73e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.01e-06	3.73e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—JUN—stomach cancer	5.01e-06	3.73e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APC—stomach cancer	4.97e-06	3.7e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—HMOX1—stomach cancer	4.97e-06	3.7e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RHOA—stomach cancer	4.96e-06	3.7e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK8—stomach cancer	4.95e-06	3.68e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	4.93e-06	3.67e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	4.92e-06	3.66e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOS3—stomach cancer	4.91e-06	3.66e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—KRAS—stomach cancer	4.87e-06	3.63e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MMP9—stomach cancer	4.87e-06	3.63e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CDKN1A—stomach cancer	4.85e-06	3.61e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CXCL8—stomach cancer	4.85e-06	3.61e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HRAS—stomach cancer	4.82e-06	3.59e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCL8—stomach cancer	4.78e-06	3.56e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ERCC2—stomach cancer	4.77e-06	3.55e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—stomach cancer	4.77e-06	3.55e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—MAPK3—stomach cancer	4.76e-06	3.54e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HRAS—stomach cancer	4.75e-06	3.54e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RHOA—stomach cancer	4.75e-06	3.53e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK8—stomach cancer	4.74e-06	3.53e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1B—stomach cancer	4.73e-06	3.52e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TYMS—stomach cancer	4.72e-06	3.52e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOS3—stomach cancer	4.7e-06	3.5e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TYMS—stomach cancer	4.68e-06	3.49e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	4.68e-06	3.48e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1B—stomach cancer	4.67e-06	3.48e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTM1—stomach cancer	4.67e-06	3.48e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTM1—stomach cancer	4.63e-06	3.45e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PIK3CA—stomach cancer	4.63e-06	3.45e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6R—stomach cancer	4.61e-06	3.44e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—stomach cancer	4.61e-06	3.43e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ERBB2—stomach cancer	4.6e-06	3.42e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—stomach cancer	4.57e-06	3.4e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—stomach cancer	4.55e-06	3.39e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—MAPK1—stomach cancer	4.53e-06	3.37e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—stomach cancer	4.53e-06	3.37e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—stomach cancer	4.52e-06	3.37e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—stomach cancer	4.52e-06	3.36e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—JUN—stomach cancer	4.51e-06	3.36e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—stomach cancer	4.49e-06	3.34e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—stomach cancer	4.48e-06	3.33e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	4.48e-06	3.33e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—stomach cancer	4.46e-06	3.32e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—JUN—stomach cancer	4.45e-06	3.31e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB2—stomach cancer	4.4e-06	3.27e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ERCC2—stomach cancer	4.39e-06	3.27e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	4.39e-06	3.27e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—stomach cancer	4.38e-06	3.26e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—stomach cancer	4.37e-06	3.26e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1A—stomach cancer	4.37e-06	3.25e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL8—stomach cancer	4.36e-06	3.24e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ERCC2—stomach cancer	4.35e-06	3.24e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—stomach cancer	4.33e-06	3.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—stomach cancer	4.33e-06	3.22e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	4.33e-06	3.22e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—stomach cancer	4.33e-06	3.22e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK3—stomach cancer	4.32e-06	3.22e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SERPINE1—stomach cancer	4.32e-06	3.22e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1A—stomach cancer	4.31e-06	3.21e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTP1—stomach cancer	4.3e-06	3.2e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—stomach cancer	4.28e-06	3.19e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KRAS—stomach cancer	4.28e-06	3.18e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK8—stomach cancer	4.26e-06	3.17e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	4.26e-06	3.17e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HMOX1—stomach cancer	4.25e-06	3.16e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK8—stomach cancer	4.21e-06	3.13e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—stomach cancer	4.2e-06	3.13e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RHOA—stomach cancer	4.17e-06	3.1e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL8—stomach cancer	4.17e-06	3.1e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—stomach cancer	4.14e-06	3.09e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—stomach cancer	4.14e-06	3.08e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CAV1—stomach cancer	4.14e-06	3.08e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK3—stomach cancer	4.14e-06	3.08e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOA1—stomach cancer	4.13e-06	3.07e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—stomach cancer	4.13e-06	3.07e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOS3—stomach cancer	4.13e-06	3.07e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK1—stomach cancer	4.11e-06	3.06e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—stomach cancer	4.11e-06	3.06e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—stomach cancer	4.1e-06	3.05e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—stomach cancer	4.09e-06	3.05e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	4.07e-06	3.03e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—stomach cancer	4.06e-06	3.02e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—JUN—stomach cancer	4.05e-06	3.02e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—stomach cancer	4.02e-06	3e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TYMS—stomach cancer	4e-06	2.98e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—stomach cancer	3.96e-06	2.95e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTM1—stomach cancer	3.96e-06	2.95e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.95e-06	2.94e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—stomach cancer	3.94e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—stomach cancer	3.94e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK1—stomach cancer	3.94e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—stomach cancer	3.94e-06	2.93e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	3.93e-06	2.93e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	3.93e-06	2.92e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—stomach cancer	3.9e-06	2.9e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—stomach cancer	3.88e-06	2.89e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KRAS—stomach cancer	3.88e-06	2.89e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—stomach cancer	3.88e-06	2.89e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—JUN—stomach cancer	3.87e-06	2.89e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB2—stomach cancer	3.86e-06	2.87e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—stomach cancer	3.85e-06	2.86e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK8—stomach cancer	3.83e-06	2.85e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CAV1—stomach cancer	3.81e-06	2.83e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOA1—stomach cancer	3.8e-06	2.83e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CAV1—stomach cancer	3.77e-06	2.81e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—stomach cancer	3.77e-06	2.81e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOA1—stomach cancer	3.76e-06	2.8e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	3.76e-06	2.8e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK3—stomach cancer	3.72e-06	2.77e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CA—stomach cancer	3.72e-06	2.77e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ERCC2—stomach cancer	3.72e-06	2.77e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KRAS—stomach cancer	3.72e-06	2.77e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK3—stomach cancer	3.67e-06	2.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK8—stomach cancer	3.67e-06	2.73e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL8—stomach cancer	3.66e-06	2.72e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARG—stomach cancer	3.64e-06	2.71e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—stomach cancer	3.64e-06	2.71e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—stomach cancer	3.62e-06	2.7e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.61e-06	2.68e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—stomach cancer	3.57e-06	2.66e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1B—stomach cancer	3.57e-06	2.66e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CA—stomach cancer	3.57e-06	2.66e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK1—stomach cancer	3.54e-06	2.64e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—stomach cancer	3.54e-06	2.64e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—stomach cancer	3.54e-06	2.64e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—stomach cancer	3.5e-06	2.61e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK1—stomach cancer	3.5e-06	2.6e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—stomach cancer	3.5e-06	2.6e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—stomach cancer	3.5e-06	2.6e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—stomach cancer	3.48e-06	2.59e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—stomach cancer	3.45e-06	2.57e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CA—stomach cancer	3.42e-06	2.54e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—stomach cancer	3.41e-06	2.54e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—JUN—stomach cancer	3.4e-06	2.53e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—stomach cancer	3.39e-06	2.52e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—stomach cancer	3.35e-06	2.5e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK3—stomach cancer	3.35e-06	2.49e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KRAS—stomach cancer	3.35e-06	2.49e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARG—stomach cancer	3.35e-06	2.49e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARG—stomach cancer	3.32e-06	2.47e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—stomach cancer	3.31e-06	2.46e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KRAS—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALB—stomach cancer	3.27e-06	2.44e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—stomach cancer	3.26e-06	2.42e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CAV1—stomach cancer	3.22e-06	2.4e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK8—stomach cancer	3.22e-06	2.4e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOA1—stomach cancer	3.22e-06	2.4e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK3—stomach cancer	3.2e-06	2.38e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK1—stomach cancer	3.19e-06	2.37e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—stomach cancer	3.19e-06	2.37e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—stomach cancer	3.16e-06	2.35e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—stomach cancer	3.16e-06	2.35e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CA—stomach cancer	3.15e-06	2.34e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NOS3—stomach cancer	3.13e-06	2.33e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—stomach cancer	3.11e-06	2.32e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.08e-06	2.29e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CA—stomach cancer	3.07e-06	2.29e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK1—stomach cancer	3.05e-06	2.27e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—stomach cancer	3.05e-06	2.27e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CA—stomach cancer	3.03e-06	2.26e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—stomach cancer	3.02e-06	2.25e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KRAS—stomach cancer	3.01e-06	2.24e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALB—stomach cancer	3.01e-06	2.24e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALB—stomach cancer	2.98e-06	2.22e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—stomach cancer	2.97e-06	2.21e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.97e-06	2.21e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—stomach cancer	2.94e-06	2.19e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—stomach cancer	2.94e-06	2.19e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CA—stomach cancer	2.93e-06	2.18e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NOS3—stomach cancer	2.88e-06	2.14e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.88e-06	2.14e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—stomach cancer	2.86e-06	2.13e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NOS3—stomach cancer	2.85e-06	2.12e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—stomach cancer	2.84e-06	2.12e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARG—stomach cancer	2.83e-06	2.11e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.81e-06	2.09e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—stomach cancer	2.81e-06	2.09e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	2.76e-06	2.06e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—stomach cancer	2.73e-06	2.04e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—stomach cancer	2.72e-06	2.03e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—stomach cancer	2.69e-06	2e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.68e-06	1.99e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—stomach cancer	2.67e-06	1.99e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—stomach cancer	2.67e-06	1.99e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.64e-06	1.97e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—stomach cancer	2.63e-06	1.96e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—stomach cancer	2.61e-06	1.94e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—stomach cancer	2.56e-06	1.9e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—stomach cancer	2.56e-06	1.9e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALB—stomach cancer	2.55e-06	1.9e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KRAS—stomach cancer	2.53e-06	1.88e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—stomach cancer	2.45e-06	1.82e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—stomach cancer	2.45e-06	1.82e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NOS3—stomach cancer	2.44e-06	1.82e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—stomach cancer	2.34e-06	1.74e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	2.32e-06	1.73e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—stomach cancer	2.25e-06	1.67e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—stomach cancer	2.23e-06	1.66e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—stomach cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—stomach cancer	2.06e-06	1.53e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.76e-06	1.31e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.62e-06	1.21e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.61e-06	1.2e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.37e-06	1.02e-05	CbGpPWpGaD
